Skip to content

The Follow-up of Mesh/Native Tissue Complications Study(Part II)

A Multi-center Study: The Follow-up of Complications for Women Having Pelvic Reconstruction Surgery With Mesh/Native Tissue(Part II).

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03617211
Enrollment
1530
Registered
2018-08-06
Start date
2018-06-01
Completion date
2023-12-31
Last updated
2018-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Organ Prolapse

Keywords

pelvic reconstructive surgery, mesh, native tissue, tape, complications, Category-time-site (CTS) coding

Brief summary

To study the incidence and distribution of complications after different pelvic reconstruction surgeries (mesh/native tissue) in multi-centers. The investigators aimed to report and summarize the postoperative complications diagnosed in the prior 1 year, 3 years and 5 years respectively, according to the International Urogynecological AssociationInternational Continence Society(IUGA-ICS) Complication Classification Coding(Category-Time-Site coding system) .

Detailed description

Patients are inferred to 27 tertiary hospitals with the complaint of de novo complications after pelvic reconstructive surgeries using mesh, tape and native tissue between June 2018 and June 2023. The subjects include patients who accept treatment not only at 27 participating hospitals but also from other hospital. And the date of surgeries carried is not restricted in the study period. This is a study of real world. The researchers focus to investigate the incidence of complications in clinical practice.

Interventions

None listed

Sponsors

Peking University People's Hospital
CollaboratorOTHER
Qilu Hospital of Shandong University
CollaboratorOTHER
Obstetrics & Gynecology Hospital of Fudan University,Shanghai Red House Obstetrics & Gynecology Hospital
CollaboratorUNKNOWN
Peking University Third Hospital
CollaboratorOTHER
First Hospitals affiliated to the China PLA General Hospital
CollaboratorOTHER_GOV
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
CollaboratorOTHER
Tongji Hospital
CollaboratorOTHER
The First Affiliated Hospital of Guangzhou Medical University
CollaboratorOTHER
The First Affiliated Hospital with Nanjing Medical University
CollaboratorOTHER
Wuxi Obsetrics & Gynecology Hospital
CollaboratorUNKNOWN
Fuzhou General Hospital
CollaboratorOTHER
The First Affiliated Hospital of Jinan Hospital
CollaboratorUNKNOWN
Women's Hospital School Of Medicine Zhejiang University
CollaboratorOTHER
Renmin Hospital of Wuhan University
CollaboratorOTHER
The Third Hospital Affiliated Zhengzhou University
CollaboratorUNKNOWN
Shengjing Hospital
CollaboratorOTHER
General Hospital of Ningxia Medical University
CollaboratorOTHER
The Second Hospital of Hebei Medical University
CollaboratorOTHER
Gansu Provincial Maternal and Child Health Care Hospital
CollaboratorOTHER
First Affiliated Hospital of Xinjiang Medical University
CollaboratorOTHER
Yantai Yuhuangding Hospital,Medical College, Qingdao University
CollaboratorUNKNOWN
Southwest Hospital, China
CollaboratorOTHER
West China Second University Hospital
CollaboratorOTHER
Jiangxi Maternal and Child Health Hospital
CollaboratorOTHER
Chongqing Medical University
CollaboratorOTHER
Shanxi Coal Central Hospital
CollaboratorUNKNOWN
Peking Union Medical College Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* 1\) Patients are inferred to the clinic with the complaint of de novo complications after pelvic reconstructive surgeries with mesh,tape or native tissue. * 2\) Pelvic reconstructive surgeries include but not limited to open/laparoscopic sacrocolpopexy (Y-shape tape/self-cut synthesized mesh), anterior, apical, posterior or total pelvic reconstruction with trans-vaginal mesh(commercial mesh kits or self-cut synthesized mesh), repair using native tissue(sacrospinous ligament fixation, high uterosacral ligament suspension, ischial spinous fascia fixation, the Lefort operation) and as well as anti-urinary incontinence surgeries(tension-free vaginal tape). * 3\) Both primary and repeated pelvic surgery are included.

Exclusion criteria

* If the same patient who developed complications after pelvic floor reconstructive surgeries has been diagnosed and reported in 27 participating hospitals, and again treated for the same code complication in other 26 hospitals, she will be ruled out.

Design outcomes

Primary

MeasureTime frameDescription
The frequency and ratio of different postoperative complications1-year;3-year;5-yearCalculate the frequency(reported in number of cases) and ratio(reported in percentage, %) of different complications reported from 27 tertiary hospitals in the past year or 3 years or 5 years, respectively.The complications occurred after pelvic reconstructive surgeries, especially mesh/native tissue related,are classified by IUGA-ICS CTS(category-time-site)coding system.

Secondary

MeasureTime frameDescription
The distribution of complications after each kind of pelvic reconstructive surgery1-year;3-year;5-yearFor each kind of surgery,the distribution of different postoperative complications, classified by the IUGA-ICS coding system, is expressed in frequency (reported in number of cases) and ratio(reported in percentage, %).
The percentage of various pelvic reconstructive surgeries under the same complication classification coding.1-year;3-year;5-yearAnalyze and calculate the percentage of different surgical method when they present the complication with the same IUGA-ICS coding.

Countries

China

Contacts

Primary ContactShuo Liang, MD
leahleung@foxmail.com+86 13718879529
Backup ContactLan Zhu, MD
zhu_julie@vip.sina.com+86 123911714696

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026